Addiction Psychophysiology Laboratory
Paul Cinciripini, Ph.D.
The Addiction Psychophysiology Laboratory (APL) focuses on identifying the neurobiological mechanisms underlying nicotine dependence and withdrawal and translating this knowledge to assist those wishing to quit smoking. Researchers in the APL use electroencephalography (EEG), event-related potentials (ERP), functional magnetic resonance imaging (fMRI), impedance cardiography, skin conductance, and electromyography (EMG) to study nicotine addiction in humans.
Recent work has focused on psychophysiological effects of nicotine during stress, individual differences in the effects of nicotine on EEG and cardiovascular activity, genetic factors treatment outcome, pharmacogenetic effects of antidepressants during smoking cessation, and studies using startle probe and EEG/ERP methodology to examine the relations between genetics, emotional reactivity, nicotine exposure and nicotine withdrawal.
The Addiction Psychophysiology Laboratory is headed by Paul M. Cinciripini, Ph.D. Dr. Cinciripini is a Professor and Deputy Chair of the Department of Behavioral Science, and he is the Director of the Tobacco Treatment Program, at the University of Texas MD Anderson Cancer Center.